|
CI26-10126
|
Clearing pathological proteins in Frontotemporal Dementia by restoring blood-brain barrier function.
|
Giuseppe Battaglia
|
Fundació Institut de Bioenginyera de Catalunya
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10149
|
Proximity–induced degradation of KRAS G12C via localized Fenton chemistry
|
Gonçalo Bernardes
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Research Consortium
|
University of Cambridge
Fundação GIMM - Gulbenkian Institute for Molecular Medicine
|
Javier Bonet-Aleta
Cong Tang
|
STAGE 1
|
Therapeutics
|
|
CI26-10166
|
Purine nucleobases as enhancers of dNTPs synthesis to treat mitochondrial DNA maintenance disorders.
|
Ramon Martí
|
Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)
|
Research Consortium
|
Universitat de Barcelona
|
Marçal Pastor Anglada
|
STAGE 1
|
Therapeutics
|
|
CI26-10215
|
Biocatalytic Hubs for Fast Precision in PKU Management
|
Tiago Cordeiro
|
Universidade Nova de Lisboa
|
Research Consortium
|
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento
|
Paula Leandro
|
STAGE 1
|
Medical Devices
|
|
CI26-10257
|
First-in-class DSTYK kinase inhibitor as a novel targeted therapy for cancer treatment
|
Karmele Valencia
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10313
|
A First-in-Class PROTAC Drug for Complete YES1 Ablation to eradicate Solid Tumors
|
Alfonso Calvo
|
Universidad de Navarra
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10395
|
DNA-Scaffolded Lateral Flow Assay for Enhanced Serological Detection of Strongyloidiasis
|
Claudio Parolo
|
FURV-Fundació Universitat Rovira i Virgili
|
Research Consortium
|
Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE
Institut de Salut Global de Barcelona (ISGlobal)
|
Gabriel Ortega
Jose Muñoz
|
STAGE 1
|
Medical Devices
|
|
CI26-10426
|
Generation of a first-in-class inhibitor targeting ligand-dependent Hedgehog signaling in cancer
|
Josep Roma
|
Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10469
|
Breaking Diagnostic Barriers in Rare Metabolic Disorders: A Paradigm Shift for Life-Saving Screening of CACT Deficiency in Newborns
|
Jose Luis Chiara
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Research Consortium
|
Fundación para la Investigación e Innovación Biosanitaria en el Principado de Asturias
Universidad del Pais Vasco (UPV/EHU)
|
Maria Dolores Chiara Romero
Virginia Martinez Martinez
|
STAGE 1
|
Diagnostics
|
|
CI26-10518
|
Personalized 3D-Printed Offloading Orthoses for Diabetic Foot Risk Management (3D-FootCare)
|
Raquel Leirós
|
Universidad de León
|
Research Consortium
|
Universidade da Coruña
Universidad de Extremadura
|
María Elena Arce
Jesús Manuel Rodríguez
|
STAGE 1
|
Medical Devices
|
|
CI26-10666
|
Beta cell-targeted RNA splicing therapy for diabetes
|
Manuel Irimia
|
Universitat Pompeu Fabra (UPF)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10680
|
LUPIN: Learning User Physiological Intent Networks for Motor Intent Decoding in Brain Computer Interfaces
|
Nuno Garcia
|
FCiências.ID – Associação para a Investigação e Desenvolvimento de Ciências
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Medical Devices
|
|
CI26-10681
|
Single-Step Arthroscopic Repair of Chondral Defects with Native-Like Mechanics
|
Nuria Oliva
|
Universitat Ramon Llull
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Medical Devices
|
|
CI26-10741
|
ToleriGen: From Lifelong Treatment to a Cure for Multiple Sclerosis
|
Federico Fondelli
|
Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10752
|
NEWTON Biotwins
|
Ángel Goñi
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Digital Health
|
|
CI26-20059
|
Low intensity focused ultrasound device for neurorepair of the spinal cord in MS and ALS
|
Pablo Villoslada
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Medical Devices
|
|
CI26-20062
|
Enhancing rAAV Production Platforms for Scalable, Cost-Effective Gene Therapy Manufacturing
|
Jose Miguel Escandell
|
Instituto de Biologia Experimental e Tecnológica
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Therapeutics
|
|
CI26-20123
|
Advancing Regulatory Pathways for Aurkine Chemotherapeutics to First-in-Human Trials
|
Jesús Bañales
|
Asociación Instituto de Investigación Sanitaria Biogipuzkoa
|
Research Consortium
|
Universidad del Pais Vasco (UPV/EHU)
Fundación para la Investigación Biomédica del Hospital Gregorio Marañón
Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz
|
Fernando Cossío
Aitana Calvo
Angela Lamarca
|
STAGE 2
|
Therapeutics
|
|
CI26-20264
|
A novel switchable CAR-T technology for cancer treatment
|
Rafael Moreno
|
Fundació Institut d´Investigació Biomèdica de Bellvitge (IDIBELL)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Therapeutics
|
|
CI26-20295
|
FLASH Radiotherapy – Comprehensive Assurance & Reliability Engine
|
Faustino Gómez
|
Universidad de Santiago de Compostela
|
Research Consortium
|
Institut Curie
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Sophie Heinrich
Consuelo Guardiola
|
STAGE 2
|
Medical Devices
|
|
CI26-20644
|
TheraCluster: Metastasis-centric therapeutic stratification
|
Manuel Valiente
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Diagnostics
|
|
CI26-20711
|
High-sensitive Copy Number Alterations to asses Homologous Recombination Deficiency in Liquid Biopsy
|
ANA VIVANCOS
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Diagnostics
|
|
CI26-2U034
|
Improving taxol response through the manipulation of the cancer tubulin code
|
Sonia Silva
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Research Consortium
|
Universidade do Porto
|
Fernanda Borges
|
STAGE 2
|
Therapeutics
|
|
CI26-2U063
|
Biomimetic Bacterial NanoCellulose medical device with gradient porosity for osteochondral repair
|
MIGUEL GAMA
|
Universidade do Minho
|
Research Consortium
|
Universidade de Aveiro
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
Universidade de Trás-os-Montes e Alto Douro
|
Florinda Mendes Costa Costa
Silvia Alexandra Rodrigues Mendes Ferreira
José Eduardo Pereira
|
STAGE 2
|
Medical Devices
|
|
CI26-2U074
|
Pre-clinical development of a multiantigen vehiculized DNA vaccine to elicit immunity against Klebsiella pneumoniae infections
|
Mireia López
|
Universitat de Girona
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Therapeutics
|
|
CI26-2U322
|
CELLECTED 2 - Stage 2 of An Innovative Approach for Non-Invasive Bladder Cancer Detection and Patient Monitoring
|
Raphaël Canadas
|
Universidade do Porto
|
Research Consortium
|
Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência - INESC TEC
|
Hélder Oliveira
|
STAGE 2
|
Diagnostics
|
|
CI26-2U369
|
CarboSign7 for cancer diagnosis: Biosampling optimization and validation for gastric and lung cancer
|
Oscar Pozo
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
Research Consortium
|
Fundació Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
|
Adelaida García
|
STAGE 2
|
Diagnostics
|
|
CI26-30269
|
An attenuated and targeted version of interleukin 12 towards the clinic
|
Pedro Berraondo
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 3
|
Therapeutics
|
|
CI26-3U433
|
Microbiome-associated biomarkers for improved anal cancer prevention
|
Sergio Serrano-Villar
|
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
|
Individual proposal
|
N/A
|
N/A
|
STAGE 3
|
Diagnostics
|
|
CI26-3U693
|
Targeting CDK16-18 as a novel strategy against aggressive cancers
|
Marcos Malumbres
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 3
|
Therapeutics
|
